Learn More
Description
A non-specific inhibitor of adenosine 3',5'-cyclic monophosphate phosphodiesterase (cAMP PDE)4, significantly more effective than theophylline. Also inhibits cGMP phosphodiesterases. IBMX inhibits cyclic nucleotide PDE with subsequent inhibition of cyclic nucleotide hydrolysis, resulting in accumulation of cyclic AMP and guanosine 3',5'-cyclic monophosphate.
- Inhibits phenylephrine-induced release of 5-hydroxytryptamine from neuroendocrine epithelial cells of the airway mucosa (IC50: 1.3μM)
- Serves as an adenosine receptor antagonist
- Inhibits ion channels in the neuromuscular junction, GH3 cells, and vascular smooth muscle cells
- Induces calcium release from intracellular stores in sensory neurons
- Inhibits the growth of carcinoma cells both in vivo and in vitro in mice
Spécification
Spécification
| Melting Point | 195°C to 202°C |
| Quantity | 250 mg |
| Formula Weight | 222.25 |
| Physical Form | Powder |
Sécurité et traitement
- 3-Isobutyl-1-methylxanthine
- Warning
- Acute toxicity Category 4
- H302-Harmful if swallowed.
- P264-Wash thoroughly after handling.
- P270-Do not eat, drink or smoke when using this product.
- P301+P312-IF SWALLOWED: Call a POISON CENTER or doctor/physician/ if you feel unwell.
- P330-Rinse mouth.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
- MIXTURE LIST-Contains : 3-Isobutyl-1-methylxanthine
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
